334 related articles for article (PubMed ID: 10611139)
1. Kinetics and disposition of hexarelin, a peptidic growth hormone secretagogue, in rats.
Roumi M; Marleau S; du Souich P; Maggi T; Deghenghi R; Ong H
Drug Metab Dispos; 2000 Jan; 28(1):44-50. PubMed ID: 10611139
[TBL] [Abstract][Full Text] [Related]
2. The absorption, distribution, metabolism and excretion of rofecoxib, a potent and selective cyclooxygenase-2 inhibitor, in rats and dogs.
Halpin RA; Geer LA; Zhang KE; Marks TM; Dean DC; Jones AN; Melillo D; Doss G; Vyas KP
Drug Metab Dispos; 2000 Oct; 28(10):1244-54. PubMed ID: 10997947
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and disposition of L-692,429. A novel nonpeptidyl growth hormone secretagogue in preclinical species.
Leung KH; Cohn DA; Miller RR; Doss GA; Stearns RA; Simpson RE; Feeney WP; Chiu SH
Drug Metab Dispos; 1996 Jul; 24(7):753-60. PubMed ID: 8818572
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys.
Sugimoto T; Hayashi T; Okita A; Morino A
Arzneimittelforschung; 1996 Feb; 46(2):106-13. PubMed ID: 8720298
[TBL] [Abstract][Full Text] [Related]
5. The effects of dose, route, and repeated dosing on the disposition and kinetics of tetrabromobisphenol A in male F-344 rats.
Kuester RK; Sólyom AM; Rodriguez VP; Sipes IG
Toxicol Sci; 2007 Apr; 96(2):237-45. PubMed ID: 17234645
[TBL] [Abstract][Full Text] [Related]
6. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
[TBL] [Abstract][Full Text] [Related]
7. Disposition, metabolism, and excretion of U-71038, a novel renin inhibitor peptide, in the rat.
Greenfield JC; Cook KJ; O'Leary IA
Drug Metab Dispos; 1989; 17(5):518-25. PubMed ID: 2573495
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics, tissue distribution, metabolism, and excretion of celecoxib in rats.
Paulson SK; Zhang JY; Breau AP; Hribar JD; Liu NW; Jessen SM; Lawal YM; Cogburn JN; Gresk CJ; Markos CS; Maziasz TJ; Schoenhard GL; Burton EG
Drug Metab Dispos; 2000 May; 28(5):514-21. PubMed ID: 10772629
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human parathyroid hormone 1-34: pharmacokinetics, tissue distribution and excretion in rats.
Hu Z; Niu H; Yang X; Li H; Sang G; Li B
Int J Pharm; 2006 Jul; 317(2):144-54. PubMed ID: 16621369
[TBL] [Abstract][Full Text] [Related]
10. Dose-dependent pharmacokinetics of 1-(2-deoxy-beta-D- ribofuranosyl)-2,4-difluoro-5-iodobenzene: a potential mimic of 5-iodo-2'-deoxyuridine.
Khalili P; Naimi E; Sun WY; Knaus EE; Wiebe LI
Biopharm Drug Dispos; 2003 Dec; 24(9):385-95. PubMed ID: 14689467
[TBL] [Abstract][Full Text] [Related]
11. Absorption, distribution, metabolism and excretion of telmesteine, a mucolitic agent, in rat.
Lee J; Son J; Rhee SW; Kim DH
Xenobiotica; 2003 Jul; 33(7):755-65. PubMed ID: 12893524
[TBL] [Abstract][Full Text] [Related]
12. Metabolism, disposition, excretion, and pharmacokinetics of levormeloxifene, a selective estrogen receptor modulator, in the rat.
Mountfield RJ; Kiehr B; John BA
Drug Metab Dispos; 2000 May; 28(5):503-13. PubMed ID: 10772628
[TBL] [Abstract][Full Text] [Related]
13. Metabolism, pharmacokinetics, tissue distribution, and excretion of [14C]CP-424391 in rats.
Khojasteh-Bakht SC; O'donnell JP; Fouda HG; Potchoiba MJ
Drug Metab Dispos; 2005 Jan; 33(1):190-9. PubMed ID: 15486077
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of G3139, a phosphorothioate oligodeoxynucleotide antisense to bcl-2, after intravenous administration or continuous subcutaneous infusion to mice.
Raynaud FI; Orr RM; Goddard PM; Lacey HA; Lancashire H; Judson IR; Beck T; Bryan B; Cotter FE
J Pharmacol Exp Ther; 1997 Apr; 281(1):420-7. PubMed ID: 9103525
[TBL] [Abstract][Full Text] [Related]
15. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 1st communication: absorption, distribution, metabolism and excretion after topical application and subcutaneous administration in rats.
Mizojiri K; Okabe H; Sugeno K; Esumi Y; Takaichi M; Miyake T; Seki H; Inaba A
Arzneimittelforschung; 1997 Jan; 47(1):59-69. PubMed ID: 9037446
[TBL] [Abstract][Full Text] [Related]
16. Absorption, distribution, metabolism and excretion of YM466, a novel factor Xa inhibitor, in rats.
Mano Y; Sonoda T; Nakamura E; Usui T; Kamimura H
Biopharm Drug Dispos; 2004 Sep; 25(6):253-60. PubMed ID: 15334624
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of 9-nitro-20(S)-camptothecin in rats.
Zhong DF; Li K; Xu JH; Du Y; Zhang YF
Acta Pharmacol Sin; 2003 Mar; 24(3):256-62. PubMed ID: 12617776
[TBL] [Abstract][Full Text] [Related]
18. Metabolite profiles of degarelix, a new gonadotropin-releasing hormone receptor antagonist, in rat, dog, and monkey.
Sonesson A; Koechling W; Stalewski J; Tankó LB; Rasmussen BB
Drug Metab Dispos; 2011 Oct; 39(10):1895-903. PubMed ID: 21768273
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and delta1-cortienic acid excretion after intravenous administration of prednisolone and loteprednol etabonate in rats.
Wu WM; Tang Y; Buchwald P; Bodor N
Pharmazie; 2010 Jun; 65(6):412-6. PubMed ID: 20614688
[TBL] [Abstract][Full Text] [Related]
20. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 2nd communication: absorption, distribution and excretion after single and consecutive subcutaneous administration in rats.
Mizojiri K; Okabe H; Sugeno K; Esumi Y; Takaichi M; Tsutsumi S; Harada T; Miyoshi R; Inaba A
Arzneimittelforschung; 1997 Feb; 47(2):195-200. PubMed ID: 9079240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
